hif < high < higher

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 102.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000027 (2010)	Taio Naniwa [Japon] ; Rei Ito [Japon] ; Maiko Watanabe [Japon] ; Yoshihito Hayami [Japon] ; Shinji Maeda [Japon] ; Kaneshige Sasaki [Japon] ; Shiho Iwagaitsu [Japon]	Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still’s disease
000031 (2005)	Shumpei Yokota [Japon] ; Takako Miyamae [Japon] ; Tomoyuki Imagawa [Japon] ; Shigeki Katakura [Japon] ; Rumiko Kurosawa [Japon] ; Masaaki Mori [Japon]	Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
000043 (2009)	Kazuko Matsumoto [Japon] ; Takao Nagashima [Japon] ; Shino Takatori [Japon] ; Yuta Kawahara [Japon] ; Masaki Yagi [Japon] ; Masahiro Iwamoto [Japon] ; Hitoaki Okazaki [Japon] ; Seiji Minota [Japon]	Glucocorticoid and cyclosporine refractory adult onset Still’s disease successfully treated with tocilizumab
000051 (2008)	Atsushi Taga [Japon] ; Soichiro Kita ; Kaori Nishiura [Japon] ; Tomonori Hayashi [Japon] ; Mitsuhiro Kinoshita ; Atsushi Sato [Japon] ; Kentaro Suzuki [Japon] ; Shuji Kodama [Japon] ; Kazuaki Kakehi	Analysis of an antibody pharmaceutical, tocilizumab, by capillary electrophoresis using a carboxylated capillary
000056 (2015)	Yuliya Hellwig [Allemagne] ; Young E. Yoo [Allemagne] ; Marie L. Re [Allemagne] ; Oliver Andres [Allemagne] ; Matthias Braun [Allemagne] ; Paul G. Schlegel [Allemagne] ; Matthias Wölfl [Allemagne]	Fulminant skin GvHD with a cytokine pattern resemblant of cytokine release syndrome successfully treated with multimodal immunosuppression including tocilizumab
000057 (2007)	Peter Taylor [Royaume-Uni]	IL‐6 inhibition in the treatment of rheumatoid arthritis
000061 (2016)	Mats Jerkeman [Suède] ; Ola Lindén [Suède]	Long‐term remission in idiopathic Castleman's disease with tocilizumab followed by consolidation with high‐dose melphalan—two case studies
000066 (2013)	Kanae Tani [Japon] ; Risa Takayanagi [Japon] ; Haruko Yokoyama [Japon] ; Yasuhiko Yamada [Japon]	Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy
000069 (2016)	Nozomu Yanaihara [Japon] ; Yukihiro Hirata [Japon] ; Noriko Yamaguchi [Japon] ; Yukiko Noguchi [Japon] ; Misato Saito [Japon] ; Chie Nagata [Japon] ; Satoshi Takakura [Japon] ; Kyosuke Yamada [Japon] ; Aikou Okamoto [Japon]	Antitumor effects of interleukin‐6 (IL‐6)/interleukin‐6 receptor (IL‐6R) signaling pathway inhibition in clear cell carcinoma of the ovary
000074 (2010)	Keiichi Sumida [Japon] ; Yoshifumi Ubara [Japon] ; Junichi Hoshino [Japon] ; Tatsuya Suwabe [Japon] ; Rikako Hiramatsu [Japon] ; Eiko Hasegawa [Japon] ; Noriko Hayami [Japon] ; Masayuki Yamanouchi [Japon] ; Naoki Sawa [Japon] ; Fumi Takemoto [Japon] ; Kenmei Takaichi [Japon]	Etanercept-refractory adult-onset Still’s disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab
000082 (2015)	Michelle Kolb [États-Unis] ; Monica Bhatia [États-Unis] ; Gay-Gaddi Madina [États-Unis] ; Prakash Satwani [États-Unis]	Effective use of tocilizumab for the treatment of steroid‐refractory gastrointestinal acute graft versus host disease in a child with very high levels of serum interleukin‐6
000085 (2011)	Hiroki Wakabayashi [Japon] ; Akihiro Sudo [Japon] ; Yosuke Nishioka [Japon] ; Masahiro Hasegawa [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon]	Repeat etanercept administration restores clinical response of patients with rheumatoid arthritis
000092 (2009)	Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon] ; Hideo Harigae [Japon]	Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice
000096 (2009)	Hiroe Sato [Japon] ; Takehito Sakai [Japon] ; Toshiaki Sugaya [Japon] ; Yasuhiro Otaki [Japon] ; Kana Aoki [Japon] ; Katsushi Ishii [Japon] ; Hidehiro Horizono [Japon] ; Hiroshi Otani [Japon] ; Asami Abe [Japon] ; Noboru Yamada [Japon] ; Hajime Ishikawa [Japon] ; Kiyoshi Nakazono [Japon] ; Akira Murasawa [Japon] ; Fumitake Gejyo [Japon]	Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis
000101 (2012)	K. Krüger [Allemagne]	Medikamentöse Interaktionen in der Rheumatologie
000133 (2009)	Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami [Japon] ; Satoshi Yamasaki [Japon] ; Takahiro Imazato [Japon] ; Naoki Iwamoto [Japon] ; Keita Fujikawa [Japon] ; Toshiyuki Aramaki [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Hiroaki Ida [Japon] ; Tomoki Origuchi [Japon] ; Yukitaka Ueki [Japon] ; Katsumi Eguchi [Japon]	Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis
000134 (2013)	F. Behrens [Allemagne] ; M. Köhm [Allemagne]	Personalisierte Medizin bei Zytokin-gerichteten Therapien
000135 (2012)	K. Krüger [Allemagne] ; J. Wollenhaupt [Allemagne] ; K. Albrecht [Allemagne] ; R. Alten [Allemagne] ; M. Backhaus [Allemagne] ; C. Baerwald [Allemagne] ; W. Bolten [Allemagne] ; J. Braun [Allemagne] ; H. Burkhardt [Allemagne] ; G. Burmester [Allemagne] ; M. Gaubitz [Allemagne] ; A. Gause [Allemagne] ; E. Gromnica-Ihle [Allemagne] ; H. Kellner [Allemagne] ; J. Kuipers [Allemagne] ; A. Krause [Allemagne] ; H.-M. Lorenz [Allemagne] ; B. Manger [Allemagne] ; H. Nü Lein [Allemagne] ; H.-G. Pott [Allemagne] ; A. Rubbert-Roth [Allemagne] ; M. Schneider [Allemagne] ; C. Specker [Allemagne] ; H. Schulze-Koops [Allemagne] ; H.-P. Tony [Allemagne] ; S. Wassenberg [Allemagne] ; U. Müller-Ladner [Allemagne]	S1-Leitlinie der DGRh zur sequenziellen medikamentösen Therapie der rheumatoiden Arthritis 2012
000148 (2013)	L. Naumann [Allemagne] ; E. Feist [Allemagne] ; G.-R. Burmester [Allemagne]	Antizytokintherapie
000175 (2012)	P. Lehmann [Allemagne] ; E. Huber [Allemagne] ; T. Dörner [Allemagne] ; M. Fleck [Allemagne]	Makrophagenaktivierungssyndrom
000183 (2008)	Susan Milius	Biology: High CO2—a gourmet boon for crop pest

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "high" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "high" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    high
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021